CLEVELAND, Ohio — Researchers at the Harrington Discovery Institute at University Hospitals have identified a new class of ...

A new research paper was published in Volume 17 of Oncotarget on May 20, 2026, titled "Microenvironmental CTHRC1 has a ...

In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

A new research paper was published in Volume 17 of Oncotarget on May 20, 2026, titled “Microenvironmental CTHRC1 has a ...

A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent ...

A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...

Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer cells in tumors and discovered a mechanism that accelerates tumor growth.

When cancer cells begin to die within tumors, they expose signals on their surface that indicate they are dying. Macrophages then detect these signals and engage in phagocytosis, where they eat the ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Several popular breakfast foods are rich in a vitamin that may prevent cancer, but what if you already have it? Here's what ...

The drug also "doubled the time of cancer growth control, nearly tripled the ability to shrink the cancer, and maintained ...